FI63595C - Foerfarande foer stabilisering av bakteriologiska prover i synnerhet urinprover - Google Patents
Foerfarande foer stabilisering av bakteriologiska prover i synnerhet urinprover Download PDFInfo
- Publication number
- FI63595C FI63595C FI790541A FI790541A FI63595C FI 63595 C FI63595 C FI 63595C FI 790541 A FI790541 A FI 790541A FI 790541 A FI790541 A FI 790541A FI 63595 C FI63595 C FI 63595C
- Authority
- FI
- Finland
- Prior art keywords
- boric acid
- samples
- urine
- bacteriological
- added
- Prior art date
Links
- 230000000721 bacterilogical effect Effects 0.000 title claims description 13
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 54
- 239000004327 boric acid Substances 0.000 claims description 53
- 210000002700 urine Anatomy 0.000 claims description 47
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 20
- 238000003860 storage Methods 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- -1 polyoxy Chemical class 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical class C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- MCPLVIGCWWTHFH-UHFFFAOYSA-L methyl blue Chemical compound [Na+].[Na+].C1=CC(S(=O)(=O)[O-])=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[NH+]C=2C=CC(=CC=2)S([O-])(=O)=O)C=2C=CC(NC=3C=CC(=CC=3)S([O-])(=O)=O)=CC=2)C=C1 MCPLVIGCWWTHFH-UHFFFAOYSA-L 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 description 25
- 238000002474 experimental method Methods 0.000 description 18
- 230000032258 transport Effects 0.000 description 18
- 241000588724 Escherichia coli Species 0.000 description 16
- 241000588769 Proteus <enterobacteria> Species 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 11
- 229960000907 methylthioninium chloride Drugs 0.000 description 11
- 241000588748 Klebsiella Species 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- PEEKVIHQOHJITP-UHFFFAOYSA-N boric acid;propane-1,2,3-triol Chemical compound OB(O)O.OCC(O)CO PEEKVIHQOHJITP-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 4
- 241000589516 Pseudomonas Species 0.000 description 4
- 229910052796 boron Inorganic materials 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 208000012868 Overgrowth Diseases 0.000 description 3
- 241000588770 Proteus mirabilis Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000019206 urinary tract infection Diseases 0.000 description 3
- 241000219470 Mirabilis Species 0.000 description 2
- OVRWHQHOBRAOMZ-UHFFFAOYSA-N OCC(O)CO.B(O)O Chemical compound OCC(O)CO.B(O)O OVRWHQHOBRAOMZ-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229960001855 mannitol Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- 241000589567 Brucella abortus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- RERVRRLGFUNERS-UHFFFAOYSA-N boron;propane-1,2,3-triol Chemical compound [B].OCC(O)CO RERVRRLGFUNERS-UHFFFAOYSA-N 0.000 description 1
- 229940056450 brucella abortus Drugs 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000020200 pasteurised milk Nutrition 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Ceramic Products (AREA)
- Amplifiers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7802147A SE419346B (sv) | 1978-02-24 | 1978-02-24 | Forfarande for stabilisering av bakteriologiska prover |
| SE7802147 | 1978-02-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI790541A FI790541A (fi) | 1979-08-25 |
| FI63595B FI63595B (fi) | 1983-03-31 |
| FI63595C true FI63595C (fi) | 1983-07-11 |
Family
ID=20334100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI790541A FI63595C (fi) | 1978-02-24 | 1979-02-19 | Foerfarande foer stabilisering av bakteriologiska prover i synnerhet urinprover |
Country Status (7)
| Country | Link |
|---|---|
| CA (1) | CA1140051A (sv) |
| DE (1) | DE2906730C2 (sv) |
| DK (1) | DK80479A (sv) |
| FI (1) | FI63595C (sv) |
| GB (1) | GB2016446B (sv) |
| NO (1) | NO147054C (sv) |
| SE (1) | SE419346B (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8800502D0 (en) * | 1988-01-11 | 1988-02-10 | Cerestar Holding Bv | Method of adding borax/boric acid to mixing/reaction-zone |
| US5505953A (en) | 1992-05-06 | 1996-04-09 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| FR2731008B1 (fr) * | 1995-02-24 | 1999-05-07 | Dev Activites Chimiques Distri | Solution aqueuse boree, notamment pour l'adjuvantation de colle amylacee |
| WO2008131499A1 (fr) * | 2007-04-26 | 2008-11-06 | Realco Sa | Procédé de traitement de la cercosporiose du bananier et composition de traitement |
| US9102700B1 (en) * | 2014-08-29 | 2015-08-11 | Vdf Futureceuticals, Inc. | Compositions and methods for borocarbohydrate complexes |
-
1978
- 1978-02-24 SE SE7802147A patent/SE419346B/sv unknown
-
1979
- 1979-02-16 NO NO790518A patent/NO147054C/no unknown
- 1979-02-16 CA CA000321844A patent/CA1140051A/en not_active Expired
- 1979-02-19 FI FI790541A patent/FI63595C/fi not_active IP Right Cessation
- 1979-02-21 GB GB7906062A patent/GB2016446B/en not_active Expired
- 1979-02-21 DE DE2906730A patent/DE2906730C2/de not_active Expired
- 1979-02-23 DK DK80479A patent/DK80479A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK80479A (da) | 1979-08-25 |
| GB2016446B (en) | 1982-12-01 |
| DE2906730A1 (de) | 1979-09-06 |
| NO147054B (no) | 1982-10-18 |
| FI790541A (fi) | 1979-08-25 |
| GB2016446A (en) | 1979-09-26 |
| SE7802147L (sv) | 1979-08-25 |
| NO147054C (no) | 1983-01-26 |
| CA1140051A (en) | 1983-01-25 |
| SE419346B (sv) | 1981-07-27 |
| NO790518L (no) | 1979-08-27 |
| FI63595B (fi) | 1983-03-31 |
| DE2906730C2 (de) | 1982-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ingham et al. | Inhibition of phagocytosis in vitro by obligate anaerobes | |
| Pressler et al. | Candida spp. urinary tract infections in 13 dogs and seven cats: predisposing factors, treatment, and outcome | |
| US3963355A (en) | Process and apparatus for analyzing specimens for the presence of microorganisms therein | |
| CN107011511B (zh) | 一种原卟啉荧光碳点及制备方法和应用 | |
| FI63595C (fi) | Foerfarande foer stabilisering av bakteriologiska prover i synnerhet urinprover | |
| Joslyn et al. | A turbidimetric method for the assay of antibiotics | |
| US5026638A (en) | Antibiotic sensitivity test for pathogenic organisms present in mastitic milk | |
| Baskett et al. | Shigella flexneri inhibition by acetic acid | |
| Boerema et al. | Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections | |
| CN106496110B (zh) | 金属β-内酰胺酶抑制剂开链吡啶羧酸衍生物及其制备方法 | |
| Demir et al. | Bloodstream infection with Oligella ureolytica in a newborn infant: a case report and review of the literature | |
| CN116773306A (zh) | 一种阴道分泌物荧光染色液及其制备方法 | |
| DE2547622C3 (de) | Test-Set | |
| Schaeffer et al. | Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biologic effects on the vaginal and fecal flora | |
| Terzi et al. | The antibacterial effects of bilirubin on gram-negative bacterial agents of sepsis | |
| Stickler et al. | N-nitrosamine generation by urinary tract infections in spine injured patients | |
| Tan et al. | Mycoplasma isolations from clinically normal cats | |
| Bodey et al. | PC-904, a new semisynthetic penicillin | |
| Saito et al. | Antibacterial action of bronopol on various bacteria, especially on Pseudomonas aeruginosa | |
| Siddartha et al. | Isolation, identification and antibiogram studies on P. aeruginosa and S. aureus from wound samples in and around Tirupati | |
| CN116396497B (zh) | 一种金属有机框架材料及其配体结构和在纳米酶中的应用 | |
| JP3612095B2 (ja) | 検体輸送用培地 | |
| Petzer et al. | Comparing effects of freezing at-196° C and-20° C on the viability of mastitis pathogens | |
| Hyman et al. | The nitrite reaction as an indicator of urinary infection | |
| Johansen et al. | Antibacterial effects of metrizoate and metrizamide on bacterial growth in vitro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: OPUS CHEMICAL |